IFP Advisors, Inc - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,318
+38533.3%
70
-69.3%
0.00%
Q4 2022$6
-100.0%
228
-18.0%
0.00%
-100.0%
Q3 2022$22,0000.0%2780.0%0.00%0.0%
Q2 2022$22,000
-8.3%
278
-7.0%
0.00%
Q1 2022$24,000
+700.0%
299
+1323.8%
0.00%
Q4 2021$3,000210.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$3,000
-25.0%
2150.0%0.00%
-100.0%
Q1 2019$4,000
-75.0%
215
-82.3%
0.00%0.0%
Q4 2018$16,000
-42.9%
1,215
+25.9%
0.00%0.0%
Q3 2018$28,000
-45.1%
965
-48.7%
0.00%
-50.0%
Q2 2018$51,000
+50.0%
1,880
+7.4%
0.00%0.0%
Q1 2018$34,0000.0%1,7500.0%0.00%0.0%
Q4 2017$34,000
+385.7%
1,750
+503.4%
0.00%
Q3 2017$7,000
+75.0%
290
+20.8%
0.00%
Q2 2017$4,000
+33.3%
2400.0%0.00%
Q1 2017$3,0000.0%2400.0%0.00%
Q4 2016$3,000
-25.0%
2400.0%0.00%
Q3 2016$4,0000.0%240
+11.6%
0.00%
-100.0%
Q1 2016$4,0002150.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders